Skip to main content
. 2023 Sep 26;13(19):3059. doi: 10.3390/diagnostics13193059

Table 1.

Comparison of features and technical outcomes between tumors treated with RFA and CA.

RFA Cryoablation p
Number of tumors 43 47
Number of patients 38 44
Mean age at treatment (years) 69.5 69.8 0.91
Male patients no. (%) 27 (71) 32 (72) 0.86
Prior RCC treatment n° (%) 12 (32) 8 (18)
Single treatment session (%) 100 100
Mean tumor size (cm) 2.3 ± 0.9 2.1 ± 0.8 0.33
Centrally located tumors n° (%) 12 (28) 26 (55) 0.008
Mean follow-up (months) 29 25 0.40
T1b tumors n° (%) 6/43 (13.9) 4/47 (8.5) 0.41
Technical failure rate n° (%) 3/43 (6.9) 1/47 (2.1) 0.30
Local tumor recurrence rate n° (%) 1/40 (2.5) 5/46 (10.8) 0.12
Major complications rate n° (%) 1/43 (2.3) 0/47 (0) 0.93
Peri-renal hematoma rate n° (%) 2 (4.6) 11 (23.4) 0.01